Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ardelyx Inc. buy bundfuture

Start price
19.01.23 / 50%
Target price
Performance (%)
End price
This prediction ended on 14.05.23 with a price of €3.98. With a performance of 55.77% the BUY prediction by bundfuture was a big success. bundfuture has 50% into this prediction

Ardelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.

Performance without dividends (%)
Name 1w 1m 1y
Ardelyx Inc. -7.414% -7.414% 36.533%
iShares Core DAX® -1.785% -1.250% 11.664%
iShares Nasdaq 100 -2.154% 0.300% 37.531%
iShares Nikkei 225® -4.028% -3.746% 17.142%
iShares S&P 500 -1.969% 0.307% 25.617%

Comments by bundfuture for this prediction

In the thread Ardelyx Inc. diskutieren

Buy Ardelyx Inc.

In the thread Trading Ardelyx Inc.
Prediction Buy
Perf. (%) 55.77%
Target price
Ends at 19.01.24

Buy beendet

Stopped prediction by bundfuture for Ardelyx Inc.

Ardelyx Inc.

Start price
Target price
Perf. (%)